Faculty & Staff Details

	Name:	Kenna Payne, Pharm.D., BCPS
	Position:	Assistant Professor, Adult Medicine Division, Amarillo
	Email:	kenna.payne@ttuhsc.edu
	Bio	Dr. Payne is an Assistant Professor at Texas Tech University Health Sciences Center School of Pharmacy. Her current clinical practice focuses on inpatient family medicine. She is a clinical pharmacist who precepts pharmacy students and participates in daily rounds with the TTUHSC School of Medicine attendings, Family Medicine residents, and medical students at Baptist-St. Anthony’s Hospital. She received her Pharm.D. from TTUHSC School of Pharmacy in Amarillo in 2005. She then completed a two-year ASHP accredited Pharmacotherapy Specialty Residency at TTUHSC School of Pharmacy in Dallas in 2007. She became a Board Certified Pharmacotherapy Specialist (BCPS) through the Board of Pharmaceutical Specialties in 2007.

Education:

July 2005- July 2007, ASHP Accredited Pharmacotherapy Specialty Residency, Texas Tech Health Sciences Center School of Pharmacy and Veterans Affairs North Texas Medical Center, Dallas, Texas.

May 2005, Doctor of Pharmacy, Texas Tech HSC School of Pharmacy, Amarillo, Texas.

Licensure:

Registered Pharmacist, License #43513, Texas State Board of Pharmacy, issued 8/4/2005

Certifications:

Board Certified Pharmacotherapy Specialist, Board of Pharmaceutical Specialties, issued 11/29/07.

Pharmacy Preceptor, Texas State Board of Pharmacy, 2006 to present.

Advanced Cardiac Life Support, American Heart Association, 2006 to present.

Basic Life Support, American Heart Association, 2003 to present.

APhA Pharmacy Based Immunization Certificate, 2004 to present.

Research Interests:

Clinical Trials Experience and Clinical Research:

Bain A, Payne K, Rahman A, Bedimo R, Maclayton D, Busti AJ. A multi-center retrospective study of the lipid lowering efficacy and safety of switching within non-nucleoside reverse transcriptase inhibitors in HIV-infected patients. Dallas VA Medical Center, The Texas Tech University Health Sciences Center School of Pharmacy Dallas Fort Worth Campus, The University of Texas Southwestern Medical Center and Texas Southern University. Funding = none. Co-investigator. [completed; submitted for publication].

Eaton S, Nguyen S, Rahman A, Bain A, Payne K, Busti AJ. The lipid lowering effects of pravastatin in NNRTI and PI-based HAART regimens in HIV-infected patients. Dallas VA Medical Center and The Texas Tech University Health Sciences Center School of Pharmacy Dallas Fort Worth Campus. Funding = none. Co-investigator. [completed; accepted for publication].

Nguyen ST, Eaton SA, Bain A, Payne K, Rahman A, Herrington J, Bedimo Busti AJ. A multi-center retrospective study on the clinical efficacy and safety on lipid lowering effects after a switch to an atazanavir/ritonavir based HAART regimen. Dallas VA Medical Center, The Texas Tech University Health Sciences Center School of Pharmacy Dallas Fort Worth Campus, Scott & White Memorial Hospital and The University of Texas Southwestern Medical Center. Funding = none. Co-investigator. [completed 12/2006, accepted for publication].

Payne K, Rahman A, Bain A, Nguyen S, Eaton S, Busti AJ, Hall RG. A multicenter retrospective evaluation of vancomycin dosing in tertiary medical centers. Dallas VA Medical Center, The Texas Tech University Health Sciences Center School of Pharmacy Dallas Fort Worth Campus, Presbyterian Hospital of Dallas, and The University of Texas Southwestern Medical Center. Funding = none. Co-investigator. [completed 2/2007, platform presentation and accepted for publication].

Rahman A, Eaton S, Nguyen S, Bain A, Payne K, Bedimo R, Busti AJ. The lipid lowering effects of simvastatin in NNRTI-based HAART regimens in HIV-infected patients compared to non-HIV-infected patiants. Dallas VA Medical Center and The Texas Tech University Health Sciences Center School of Pharmacy Dallas Fort Worth Campus. Funding = none. Co-investigator. [completed; manuscript in progress].

Publications:

Peer-reviewed journals:

Bain A, Payne K, Rahman A, Bedimo RG, Maclayton D, Rodriguez-Barradas M, Busti AJ. The lipid lowering efficacy of switching within non-nucleoside reverse transcriptase inhibitors in HIV-infected patients [Original Research]. Am J Infect Dis [submitted 12/2007].

Rahman AP, Eaton SA, Nguyen ST, Bain AM, Payne KD, Bedimo RG, Busti AJ. The lipid lowering effects of simvastatin in NNRTI-based HAART regimens in HIV-infected patients compared to non-HIV-infected patients. Pharmacotherapy [submitted 11/2007]

Hall RG, Payne KD, Rahman AP, Bain AM, Nguyen ST, Eaton SA, Busti AJ. A multicenter evaluation of vancomycin dosing in tertiary medical centers. Am J Med [Accepted Jan 2008].

Nguyen ST, Eaton SA, Bain A, Payne K, Rahman A, Herrington J, Maclayton D, Rodriguez-Barradas M, Busti AJ. The lipid lowering efficacy and safety after a switch to an atazanavir/ritonavir based HAART in HIV-infected patients: a multi-center retrospective study [Original Research]. Pharmacotherapy [Accepted, Sept 2007; to be in March 2008 issue].

Eaton SA, Rahman AP, Bain AM, Nguyen ST, Payne, KD, Busti AJ. Efficacy of pravastatin in non-nucleoside reverse transcriptase inhibitor (NNRTI) and protease inhibitor (PI)-based HAART in HIV-infected patients [Original Research]. Am J Infect Dis 2008;4(2) [Accepted Sept 2007].

Peer Reviewed Abstracts:

Bain A, Payne K, Rahman A, Bedimo R, Maclayton D, Rodriguez-Barradas M, Busti AJ. A multi-center retrospective study of the lipid lowering efficacy and safety of switching within non-nucleoside reverse transcriptase inhibitors in HIV-infected patients (abstract 103). J Clin Lipid 2007;1:149.

Eaton S, Nguyen S, Rahman A, Bain A, Payne K, Busti AJ. The lipid lowering effects of pravastatin in NNRTI and PI-based HAART regimens in HIV-infected patients (abstract 107). J Clin Lipid 2007;1:151-152.

Nguyen ST, Eaton SA, Bain A, Payne K, Rahman A, Herrington J, Maclayton D, Rodriguez-Barradas M, Busti AJ. A multi-center retrospective study on the clinical efficacy and safety on lipid lowering effects after a switch to an atazanavir/ritonavir based HAART regimen (abstract 109). J Clin Lipid 2007;1:152-153.

Rahman A, Eaton S, Nguyen S, Bain A, Payne K, Bedimo R, Busti AJ. The lipid lowering effects of simvastatin in NNRTI-based HAART regimens in HIV-infected patients compared to non-HIV-infected patients (abstract 110). J Clin Lipid 2007;1:153.

Presentations:

Payne K, Rahman A, Bain A, Nguyen S, Eaton S, Busti AJ, Hall RG. A multicenter retrospective evaluation of vancomycin dosing in tertiary medical centers. 21st ALCALDE Southwest Leadership Conference. April 19-20, 2007, San Antonio, TX.

Vancomycin Dosing in Obesity. Resident Seminar presentation. Presented to Texas Tech HSC School of Pharmacy faculty, residents, Pharm.D. candidates, and Dallas VA Medical Center pharmacists. Dallas, Texas. September, 2006.

Renal Dosing Dilemma: Multiple equations, one recommendation. Resident Seminar presentation. Presented to Texas Tech HSC School of Pharmacy faculty, residents, Pharm.D. candidates, and Dallas VA Medical Center pharmacists. Dallas, Texas. October, 2005.

Dexmedetomidine: A unique form of sedation. Grand Rounds presentation. Presented to Texas Tech HSC School of Pharmacy faculty and Pharm.D. candidates. Amarillo, Texas. April, 2005.

Ximelagatran: A new era in venous thromboembolism prophylaxis. Grand Rounds presentation. Presented to Texas Tech HSC School of Pharmacy faculty and Pharm.D. candidates. Amarillo, Texas. September, 2004.